Direct Stimulation of Angiotensin II Type 2 Receptor Enhances Spatial Memory

The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia

(2010) Costantino Iadecola   ACTA NEUROPATHOLOGICA

Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats

(2010) S Bosnyak et al.   BRITISH JOURNAL OF PHARMACOLOGY

Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB

(2010) Franziska Rompe et al.   HYPERTENSION

Angiotensin AT 2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension

(2010) Luis C. Matavelli et al.   HYPERTENSION

Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatum

(2010) Birgit Mertens et al.   NEUROPHARMACOLOGY

Chronic cerebral hypoperfusion accelerates amyloid β deposition in APPSwInd transgenic mice

(2009) Hiroshi Kitaguchi et al.   BRAIN RESEARCH

Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function

(2009) Akiko Sakata et al.   BRAIN RESEARCH

Cognitive Deficit in Amyloid-β–Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation

(2009) Kana Tsukuda et al.   HYPERTENSION

Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage

(2009) Paolo Gelosa et al.   JOURNAL OF HYPERTENSION

Telmisartan prevented cognitive decline partly due to PPAR-γ activation

(2008) Masaki Mogi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Diabetes-Associated Cognitive Impairment Is Improved by a Calcium Channel Blocker, Nifedipine

(2008) Kana Tsukuda et al.   HYPERTENSION

New therapeutic targets in the neurovascular pathway in Alzheimer’s disease

(2008) Berislav V. Zlokovic   Neurotherapeutics

Angiotensin II-induced vasodilation via type 2 receptor: Role of bradykinin and nitric oxide

(2007) Katsutoshi Yayama et al.   INTERNATIONAL IMMUNOPHARMACOLOGY